NCT06054880View on ClinicalTrials.gov

Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency

PHASE4RecruitingINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

August 31, 2025

Conditions

Ureter Injury

Interventions

DRUG

Indigotindisulfonate sodium 0.8%

Experimental contrast dye that is commonly used as a visualization aid in pelvic and abdominal surgeries and for various diagnostic procedures in medical practice.

OTHER

Saline injection 0.9%

Placebo

Trial Locations (1)

12008

RECRUITING

Albany Medical Center, Albany

All Listed Sponsors

lead

Prove pharm

INDUSTRY